327 related articles for article (PubMed ID: 25991438)
1. Promotion of Wound Healing by an Agonist of Adenosine A2A Receptor Is Dependent on Tissue Plasminogen Activator.
Montesinos MC; Desai-Merchant A; Cronstein BN
Inflammation; 2015 Dec; 38(6):2036-41. PubMed ID: 25991438
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
[TBL] [Abstract][Full Text] [Related]
3. Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.
Jögi A; Rønø B; Lund IK; Nielsen BS; Ploug M; Høyer-Hansen G; Rømer J; Lund LR
PLoS One; 2010 Sep; 5(9):e12746. PubMed ID: 20856796
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel).
Victor-Vega C; Desai A; Montesinos MC; Cronstein BN
Inflammation; 2002 Feb; 26(1):19-24. PubMed ID: 11936752
[TBL] [Abstract][Full Text] [Related]
5. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors.
Montesinos MC; Desai A; Chen JF; Yee H; Schwarzschild MA; Fink JS; Cronstein BN
Am J Pathol; 2002 Jun; 160(6):2009-18. PubMed ID: 12057906
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.
Schäfer K; Konstantinides S; Riedel C; Thinnes T; Müller K; Dellas C; Hasenfuss G; Loskutoff DJ
Circulation; 2002 Oct; 106(14):1847-52. PubMed ID: 12356640
[TBL] [Abstract][Full Text] [Related]
7. Annexin A2-Mediated Plasminogen Activation in Endothelial Cells Contributes to the Proangiogenic Effect of Adenosine A
Valls MD; Soldado M; Arasa J; Perez-Aso M; Williams AJ; Cronstein BN; Noguera MA; Terencio MC; Montesinos MC
Front Pharmacol; 2021; 12():654104. PubMed ID: 33986681
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
[TBL] [Abstract][Full Text] [Related]
9. Advantages in Wound Healing Process in Female Mice Require Upregulation A
Troncoso F; Herlitz K; Acurio J; Aguayo C; Guevara K; Castro FO; Godoy AS; San Martin S; Escudero C
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998232
[TBL] [Abstract][Full Text] [Related]
10. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
11. Topical application of the adenosine A2A receptor agonist CGS-21680 prevents phorbol-induced epidermal hyperplasia and inflammation in mice.
Arasa J; Martos P; Terencio MC; Valcuende-Cavero F; Montesinos MC
Exp Dermatol; 2014 Aug; 23(8):555-60. PubMed ID: 24889129
[TBL] [Abstract][Full Text] [Related]
12. Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors.
Montesinos MC; Gadangi P; Longaker M; Sung J; Levine J; Nilsen D; Reibman J; Li M; Jiang CK; Hirschhorn R; Recht PA; Ostad E; Levin RI; Cronstein BN
J Exp Med; 1997 Nov; 186(9):1615-20. PubMed ID: 9348321
[TBL] [Abstract][Full Text] [Related]
13. Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.
Kawao N; Tamura Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E278-88. PubMed ID: 24918201
[TBL] [Abstract][Full Text] [Related]
14. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes.
Wakita H; Matsushita K; Nishimura K; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1998 Mar; 110(3):253-8. PubMed ID: 9506444
[TBL] [Abstract][Full Text] [Related]
15. The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice.
Kawao N; Tamura Y; Horiuchi Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
PLoS One; 2015; 10(4):e0123982. PubMed ID: 25893677
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activation in healing human wounds.
Schäfer BM; Maier K; Eickhoff U; Todd RF; Kramer MD
Am J Pathol; 1994 Jun; 144(6):1269-80. PubMed ID: 8203466
[TBL] [Abstract][Full Text] [Related]
17. Urokinase-type plasminogen activator modulates mammalian circadian clock phase regulation in tissue-type plasminogen activator knockout mice.
Cooper JM; Rastogi A; Krizo JA; Mintz EM; Prosser RA
Eur J Neurosci; 2017 Mar; 45(6):805-815. PubMed ID: 27992087
[TBL] [Abstract][Full Text] [Related]
18. Mice deficient in urokinase-type plasminogen activator have delayed healing of tympanic membrane perforations.
Shen Y; Guo Y; Du C; Wilczynska M; Hellström S; Ny T
PLoS One; 2012; 7(12):e51303. PubMed ID: 23236466
[TBL] [Abstract][Full Text] [Related]
19. Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors.
Macedo L; Pinhal-Enfield G; Alshits V; Elson G; Cronstein BN; Leibovich SJ
Am J Pathol; 2007 Dec; 171(6):1774-88. PubMed ID: 17974599
[TBL] [Abstract][Full Text] [Related]
20. Targeting adenosine receptors to prevent inflammatory skin diseases.
Gessi S; Merighi S; Borea PA
Exp Dermatol; 2014 Aug; 23(8):553-4. PubMed ID: 24961687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
